Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare providers need better education and policies to serve transgender individuals effectively.

The study created a new method to test drugs that affect hormone processing in skin.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Transgender youth on hormone therapy need personalized acne treatments and supportive care.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Primary care providers should understand Geschlechtsinkongruenz to offer better care for transitioning individuals.

Creating evidence-based guidelines for gender incongruence is difficult due to the personalized nature of transgender medicine.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

Orthognathic surgeons play a key role in modifying masculine facial features to be more feminine, often improving transgender women's quality of life.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Transgender patients face more barriers to oral healthcare, leading to poorer oral health and quality of life.

Use correct terms and show sensitivity to improve transgender care in emergency departments.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.